E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
SAGE holding history
Sage Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SAGE overviewAll 13F holders of SAGEFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −18,544−100.0% | Sold out | Holders |
| Q1 2024 | 18,544 | $347.5K | <0.1% | +2,062+12.5% | Added | Holders |
| Q4 2023 | 16,482 | $357.2K | <0.1% | −4,678−22.1% | Reduced | Holders |
| Q3 2023 | 21,160 | $435.0K | <0.1% | +13,703+183.8% | Added | Holders |
| Q2 2023 | 7,457 | $351.0K | <0.1% | −1,955−20.8% | Reduced | Holders |
| Q1 2023 | 9,412 | $395.0K | <0.1% | +824+9.6% | Added | Holders |
| Q4 2022 | 8,588 | $328.0K | <0.1% | −2,753−24.3% | Reduced | Holders |
| Q3 2022 | 11,341 | $444.0K | <0.1% | +446+4.1% | Added | Holders |
| Q2 2022 | 10,895 | $352.0K | <0.1% | +2,261+26.2% | Added | Holders |
| Q1 2022 | 8,634 | $286.0K | <0.1% | +8,634 | New | Holders |